What is the equity of Jiangsu Nhwa Pharmaceutical Co this year?
Jiangsu Nhwa Pharmaceutical Co has equity of 6.43 B CNY this year.
Jiangsu Nhwa Pharmaceutical Co Equity 2024
Jiangsu Nhwa Pharmaceutical Co Equity
6.43 B CNY
Ticker
002262.SZ
ISIN
CNE100000CG8
In 2024, Jiangsu Nhwa Pharmaceutical Co's equity was 6.43 B CNY, a 14.46% increase from the 5.62 B CNY equity in the previous year.
Jiangsu Nhwa Pharmaceutical Co Aktienanalyse
What does Jiangsu Nhwa Pharmaceutical Co do?
Jiangsu Nhwa Pharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Jiangsu Nhwa Pharmaceutical Co's Equity
Jiangsu Nhwa Pharmaceutical Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Jiangsu Nhwa Pharmaceutical Co's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Jiangsu Nhwa Pharmaceutical Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Jiangsu Nhwa Pharmaceutical Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Jiangsu Nhwa Pharmaceutical Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Jiangsu Nhwa Pharmaceutical Co stock
What was the equity of Jiangsu Nhwa Pharmaceutical Co compared to the previous year?
The equity of Jiangsu Nhwa Pharmaceutical Co has increased/decreased by 14.46% increased compared to the previous year.
What impact does a high equity have on investors of Jiangsu Nhwa Pharmaceutical Co?
A high equity is advantageous for investors of Jiangsu Nhwa Pharmaceutical Co as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Jiangsu Nhwa Pharmaceutical Co?
A low equity can be a risk for investors of Jiangsu Nhwa Pharmaceutical Co, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Jiangsu Nhwa Pharmaceutical Co affect the company?
An increase in equity of Jiangsu Nhwa Pharmaceutical Co can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Jiangsu Nhwa Pharmaceutical Co affect the company?
A reduction in equity of Jiangsu Nhwa Pharmaceutical Co can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Jiangsu Nhwa Pharmaceutical Co?
Some factors that can affect the equity of Jiangsu Nhwa Pharmaceutical Co include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Jiangsu Nhwa Pharmaceutical Co so important for investors?
The equity of Jiangsu Nhwa Pharmaceutical Co is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Jiangsu Nhwa Pharmaceutical Co take to change the equity?
To change equity, Jiangsu Nhwa Pharmaceutical Co can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Jiangsu Nhwa Pharmaceutical Co pay?
Over the past 12 months, Jiangsu Nhwa Pharmaceutical Co paid a dividend of 0.2 CNY . This corresponds to a dividend yield of about 0.84 %. For the coming 12 months, Jiangsu Nhwa Pharmaceutical Co is expected to pay a dividend of 0.23 CNY.
What is the dividend yield of Jiangsu Nhwa Pharmaceutical Co?
The current dividend yield of Jiangsu Nhwa Pharmaceutical Co is 0.84 %.
When does Jiangsu Nhwa Pharmaceutical Co pay dividends?
Jiangsu Nhwa Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of July, June, May, June.
How secure is the dividend of Jiangsu Nhwa Pharmaceutical Co?
Jiangsu Nhwa Pharmaceutical Co paid dividends every year for the past 18 years.
What is the dividend of Jiangsu Nhwa Pharmaceutical Co?
For the upcoming 12 months, dividends amounting to 0.23 CNY are expected. This corresponds to a dividend yield of 0.95 %.
In which sector is Jiangsu Nhwa Pharmaceutical Co located?
Jiangsu Nhwa Pharmaceutical Co is assigned to the 'Health' sector.
Wann musste ich die Aktien von Jiangsu Nhwa Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Jiangsu Nhwa Pharmaceutical Co from 5/15/2024 amounting to 0.32 CNY, you needed to have the stock in your portfolio before the ex-date on 5/15/2024.
When did Jiangsu Nhwa Pharmaceutical Co pay the last dividend?
The last dividend was paid out on 5/15/2024.
What was the dividend of Jiangsu Nhwa Pharmaceutical Co in the year 2023?
In the year 2023, Jiangsu Nhwa Pharmaceutical Co distributed 0.2 CNY as dividends.
In which currency does Jiangsu Nhwa Pharmaceutical Co pay out the dividend?
The dividends of Jiangsu Nhwa Pharmaceutical Co are distributed in CNY.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Jiangsu Nhwa Pharmaceutical Co
Our stock analysis for Jiangsu Nhwa Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Jiangsu Nhwa Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Jiangsu Nhwa Pharmaceutical Co Revenue
- Jiangsu Nhwa Pharmaceutical Co Net Income
- Jiangsu Nhwa Pharmaceutical Co P/E
- Jiangsu Nhwa Pharmaceutical Co P/S
- Jiangsu Nhwa Pharmaceutical Co EBIT
- Jiangsu Nhwa Pharmaceutical Co Dividend
- Jiangsu Nhwa Pharmaceutical Co Stocks
- Jiangsu Nhwa Pharmaceutical Co Market capitalization
- Jiangsu Nhwa Pharmaceutical Co Debt
- Jiangsu Nhwa Pharmaceutical Co Liabilities
- Jiangsu Nhwa Pharmaceutical Co Equity
- Jiangsu Nhwa Pharmaceutical Co AAQS
- Jiangsu Nhwa Pharmaceutical Co Employees
- Jiangsu Nhwa Pharmaceutical Co ROE
- Jiangsu Nhwa Pharmaceutical Co ROA
- Jiangsu Nhwa Pharmaceutical Co ROCE